🇺🇸 FDA
Patent

US 12168688

Antibodies and variants thereof against PD-L1

granted A61KA61K2039/505A61P

Quick answer

US patent 12168688 (Antibodies and variants thereof against PD-L1) held by Nanjing Legend Biotech Co., Ltd expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61P, A61P35/00